Skip to main navigation Skip to search Skip to main content

Levels of bone formation marker P1NP in individuals over 50 years: a systematic review and meta-analysis

  • Elahe Hesari
  • , Sepideh Hajivalizadeh
  • , Mohammad Javad Mansourzadeh
  • , Kazem Khalagi
  • , Noushin Fahimfar
  • , Mahnaz Sanjari
  • , Zahra Cheraghi
  • , Safoora Gharibzadeh
  • , Kiarash Tanha
  • , Patricia Khashayar
  • , Hossein Yarmohammadi
  • , Sara Naderpour
  • , Ahmad Mehri
  • , Sima Noorali
  • , Azad Fatahi
  • , Leila Mounesan
  • , Isa Akbarzadeh
  • , Farbod Zahedi Tajrishi
  • , Fatemeh Varse
  • , Arash Ghazbani
  • Farideh Razi, Bagher Larijani, Afshin Ostovar

Research output: Contribution to journal › Review article › peer-review

Abstract

Background: Procollagen type 1 N-terminal propeptide (P1NP) is a vital biomarker for evaluating bone formation, reflecting osteoblast activity and offering meaningful insights into bone health. Elevated P1NP levels may signal heightened bone turnover, as observed in conditions like osteoporosis. Conversely, decreased P1NP levels could serve as a prognostic indicator for fracture risk stratification in the elderly population. Objectives: This study aimed to establish P1NP levels to enhance diagnostic and therapeutic methods in evaluating bone health. Methods: A systematic literature search were performed across multiple databases until April 15, 2023, focusing on articles that measured serum P1NP levels in healthy individuals aged 50 and older. After removing duplicates, two reviewers evaluated titles and abstracts of potentially relevant studies. Data were extracted on authors, publication year, sample size, laboratory kits used, participants’ fasting status, sex, and serum P1NP levels using a pre-designed data sheet. The risk of bias was assessed with the Newcastle Ottawa checklist, and pooled mean P1NP levels were estimated using Stata software, with statistical heterogeneity analysed through Cochran’s Q test and the I2 statistic. Results: Out of 11,011 studies identified, 49 met the inclusion criteria after screening and removing 4,227 duplicates. The pooled P1NP levels were 39.6 ng/mL for males and 48.5 ng/mL for females, with a combined level of 46.5 ng/mL. Under fasting conditions, P1NP levels were 40.0 ng/mL for males and 49.7 ng/mL for females. Funnel plot analysis suggested publication bias, but the overall quality of the studies was assessed as generally strong. Conclusion: The current study points out the necessity for the determination of sex-specific values for P1NP, highlighting elevated P1NP levels in women to be associated with a higher risk of osteoporosis.

Original languageEnglish (US)
Article number143
JournalJournal of Diabetes and Metabolic Disorders
Volume25
Issue number1
DOIs
StatePublished - Jun 2026

Bibliographical note

Publisher Copyright:
© The Author(s), under exclusive licence to Tehran University of Medical Sciences 2026.

Keywords

  • Bone formation
  • Bone remodelling
  • Bone turnover marker
  • Osteoporosis
  • P1NP
  • Procollagen type I N-terminal peptide

Fingerprint

Dive into the research topics of 'Levels of bone formation marker P1NP in individuals over 50 years: a systematic review and meta-analysis'. Together they form a unique fingerprint.

Cite this